A snapshot of the ongoing clinical research on COVID-19

Daniele Piovani1,2, Claudia Pansieri1,2, Laurent Peyrin-Biroulet3

  • 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, 20090, Italy.

F1000Research
|June 11, 2020
PubMed

Insights

Clinical trials for coronavirus disease 2019 (COVID-19) show many interventional studies have small sample sizes, potentially hindering the discovery of effective treatments. Ensuring well-designed, adequately powered trials is crucial for evidence-based strategies.

Area of Science:

  • Clinical trial design
  • Epidemiology
  • Public health

Background:

  • The COVID-19 pandemic necessitates rapid development of diagnostic, preventive, and therapeutic strategies.
  • Thousands of patients are enrolled in clinical studies during the pandemic.

Purpose of the Study:

  • To investigate the characteristics of COVID-19 studies registered in ClinicalTrials.gov.
  • To assess the incorporation of features desirable for high-quality evidence generation in these studies.

Main Methods:

  • Analysis of 945 COVID-19 studies registered in ClinicalTrials.gov as of April 28, 2020.
  • Categorization of studies by type, allocation scheme, blinding, and primary purpose.

Main Results:

  • 586 (62.0%) studies were interventional, with parallel group assignment being the most frequent (74.6%).
  • Most interventional studies were open-label, with treatment research as the primary purpose.
  • A significant number of interventional studies had small expected sample sizes, potentially compromising evidence credibility.

Conclusions:

  • Many ongoing COVID-19 interventional studies may not generate credible evidence due to inadequate sample sizes.
  • This could delay the identification of effective therapies and waste resources.
  • Well-designed, adequately powered clinical trials are essential for evidence-based decision-making during the COVID-19 pandemic.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
756
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
320
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K